M7824 in People With Recurrent Respiratory Papillomatosis

Conditions:   Recurrent Respiratory Papillomatosis;   Respiratory Papillomatosis;   Laryngeal Papilloma, Recurrent;   Human Papilloma Virus Intervention:   Drug: M7824 Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials